Biofarm Statistics

Total Valuation

Biofarm has a market cap or net worth of RON 717.35 million. The enterprise value is 602.20 million.

Market Cap	717.35M
Enterprise Value	602.20M

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	Aug 20, 2024

Share Statistics

Biofarm has 985.37 million shares outstanding. The number of shares has increased by 9.62% in one year.

Current Share Class	n/a
Shares Outstanding	985.37M
Shares Change (YoY)	+9.62%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	88.46%
Float	477.14M

Valuation Ratios

The trailing PE ratio is 9.79.

PE Ratio	9.79
Forward PE	n/a
PS Ratio	2.54
PB Ratio	1.50
P/TBV Ratio	1.51
P/FCF Ratio	29.40
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.02, with an EV/FCF ratio of 24.68.

EV / Earnings	7.50
EV / Sales	2.13
EV / EBITDA	6.02
EV / EBIT	7.30
EV / FCF	24.68

Financial Position

The company has a current ratio of 4.66, with a Debt / Equity ratio of 0.00.

Current Ratio	4.66
Quick Ratio	3.95
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.04
Interest Coverage	41,220,484.00

Financial Efficiency

Return on equity (ROE) is 17.90% and return on invested capital (ROIC) is 11.47%.

Return on Equity (ROE)	17.90%
Return on Assets (ROA)	10.05%
Return on Capital (ROIC)	11.47%
Revenue Per Employee	750,357
Profits Per Employee	213,617
Employee Count	399
Asset Turnover	0.55
Inventory Turnover	0.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.12%
50-Day Moving Average	0.75
200-Day Moving Average	0.78
Relative Strength Index (RSI)	46.46
Average Volume (20 Days)	43,209

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biofarm had revenue of RON 282.13 million and earned 80.32 million in profits. Earnings per share was 0.07.

Revenue	282.13M
Gross Profit	235.94M
Operating Income	82.44M
Pretax Income	91.15M
Net Income	80.32M
EBITDA	100.01M
EBIT	82.44M
Earnings Per Share (EPS)	0.07

Full Income Statement

Balance Sheet

The company has 116.05 million in cash and 899,350 in debt, giving a net cash position of 115.15 million or 0.12 per share.

Cash & Cash Equivalents	116.05M
Total Debt	899,350
Net Cash	115.15M
Net Cash Per Share	0.12
Equity (Book Value)	477.12M
Book Value Per Share	0.48
Working Capital	251.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.83 million and capital expenditures -37.43 million, giving a free cash flow of 24.40 million.

Operating Cash Flow	61.83M
Capital Expenditures	-37.43M
Free Cash Flow	24.40M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 83.63%, with operating and profit margins of 29.22% and 28.47%.

Gross Margin	83.63%
Operating Margin	29.22%
Pretax Margin	32.31%
Profit Margin	28.47%
EBITDA Margin	35.45%
EBIT Margin	29.22%
FCF Margin	8.65%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 4.26%.

Dividend Per Share	0.03
Dividend Yield	4.26%
Dividend Growth (YoY)	3.33%
Years of Dividend Growth	2
Payout Ratio	36.34%
Buyback Yield	-9.62%
Shareholder Yield	-5.36%
Earnings Yield	10.21%
FCF Yield	3.40%

Dividend Details

Stock Splits

The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.

Last Split Date	Apr 30, 2008
Split Type	Forward
Split Ratio	1.12001

Scores

Biofarm has an Altman Z-Score of 9.37.

Altman Z-Score	9.37
Piotroski F-Score	n/a